“Executives at Gaitherburg-based Novavax (NVAX) say the company has laid the groundwork for a vaccine to combat Middle East Respiratory Syndrome (MERS),” according to The Washington Post website from…

(PRWeb May 23, 2014)

Read the full story at http://www.prweb.com/releases/2014/05/prweb11864355.htm

Read the Rest

Tags: prweb, mers, vaccine,

Page Information

  • Keywords: PRESS RELEASE
  • Description: “Executives at Gaitherburg-based Novavax (NVAX) say the company has laid the groundwork for a vaccine to combat Middle East Respiratory Syndrome (MERS),” according to The Washington Post website from May 11, 2014 (1). polyDNA congratulates the Novavax team, and recommends Gene-Eden-VIR and Novirin, the natural antivirals.